11/5/2026

speaker
Victor
Conference Call Operator

Welcome to Strategic Education's third quarter 2026 results conference call. I will now turn the call over to Terese Wilke, Senior Director of Investor Relations for Strategic Education. Mrs. Wilke, please go ahead.

speaker
Terese Wilke
Senior Director of Investor Relations

Thank you. Hello, everyone, and welcome to Strategic Education's conference call in which we will discuss third quarter 2026 results. With us today are Karl McDonnell, President and Chief Executive Officer and Daniel Jackson, Executive Vice President and Chief Financial Officer. Following today's remarks, we will open the call for questions. Please note that this call may include forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The statements are based on current expectations and are subject to a number of assumptions, uncertainties and risks that strategic education has identified in today's press release that could cause actual results to differ materially. Further information about these and other relevant uncertainties may be found in Strategic Education's most recent annual report on Form 10-K, the 10-Q to be filed, and other filings with the Securities and Exchange Commission, as well as Strategic Education's future 8-Ks, 10-Qs, and 10-Ks. Copies of these filings and the full press release are available for viewing on our website at strategiceducation.com. and now I'd like to turn the call over to Karl. Karl, please go ahead.

speaker
Karl McDonnell
President and Chief Executive Officer

Thank you, Terese, and good morning, everyone. Our third quarter results reflect continued strength in the parts of SEI where we have been investing for growth. Education technology service, our broad employer strategy, and our U.S. healthcare portfolio. The strength in these areas, however, was mostly offset in the third quarter by our Australia segment where the environment has proved more challenging than we expected. This morning I'll briefly review the quarter and then I'll walk through each of our segments. As I do, I'll discuss the opportunities behind our intent to make 2027 a year of increased growth investments. As always, unless I note otherwise, my comments refer to adjusted results on a constant currency basis and those results exclude the $134 million non-cash impairment of goodwill and intangible assets in Australia that we recorded this quarter and which I will discuss with that segment. Third quarter revenue was $320 million, essentially flat with the prior year. We did hold operating expense growth to less than 1% resulting in operating income of $50 million, a 2% decrease and an operating margin of 15.7%, 30 basis points below the prior year. Earnings per share increased 4% to $1.69, reflecting a lower share count from share repurchases. Through the first nine months of this year, free cash flow increased 8% to $137 million. Turning now to our segments, education technology services continued its strong performance. Revenue grew 12% to $43 million, operating income grew 14% to $18 million, and operating margin expanded 80 basis points to 42.5%. Sophia Learning average total subscribers grew 22% and revenue grew 20% to $21 million. Workforce Edge ended the quarter with 83 corporate agreements covering approximately 4 million employees, and enrollments from Workforce Edge into Strayer or Capella grew 4% to roughly 4,000 students. SEI was recently named to Business Insider's 2027 list of most innovative companies, a recognition that reflects much of the work that is being done within ETS. Given the strong demand across ETS and given our desire to accelerate our product roadmap to serve that demand, Our intent is to increase our growth investments in ETS in 2027. These investments will slightly reduce the ETS segment-level operating margin next year, but will also result in higher revenue growth in our current five-year plan, defend SOFIA's market leadership position, and strengthen Workforce Edge's ability to sign new corporate clients. Turning now to U.S. Higher Education. Total U.S. higher education enrollment declined 1% to approximately 84,700 students as growth in employer-affiliated enrollment was offset by lower unaffiliated enrollment. Revenue was essentially flat at $214 million as higher revenue per student offset the enrollment decline. Our productivity initiatives continue to hold operating expense growth to less than 1%, including continued investments and growth. Operating income was $22 million, a 4% decline, and an operating margin of approximately 10%. Student retention reached 89.2%, a new all-time high for U.S. higher education. Our healthcare portfolio continues to be the strongest source of growth in U.S. higher education. Healthcare enrollment grew 9% in the quarter and now represents 54% of total U.S. higher education enrollment, up from 49% a year ago, an increase of 500 basis points over the last year. Healthcare is also central to our broad employer strategy. Roughly 38% of our healthcare enrollment comes from employer partners, and employer-affiliated enrollment overall reached 35% of U.S. higher education total enrollment, up 200 basis points from the prior year. We are now extending that portfolio into licensure track programs. Earlier this year, Capella enrolled the first cohort in its pre-licensure Bachelor of Science nursing program, and Strayer enrolled its first students in the new Associate of Applied Science and Radiologic Technology. Early demand for both programs has exceeded our initial assumptions. These two programs joined Strayer's licensed practical nurse diploma and Capella's expanded nurse practitioner portfolio all aimed at the healthcare talent our employer partners increasingly need. To support that demand, we intend to also increase our growth investments in U.S. healthcare in 2027 with funding for new programs, clinical faculty, expanded clinical and instructional capacity. This will allow programs like pre-licensure nursing and radiologic technology to grow at the pace their demand supports. Turning to Australia. Total enrollment declined 9% to approximately 17,100 students and revenue declined 7% to $64 million. The Australian team continued to manage costs well with operating expenses down 4% and operating income was $10 million compared with $12.5 million in the prior year and an operating margin of approximately 16%. The decline is entirely a function of international enrollment. Over the course of this year, the Australian government restrictions on international students have become materially more severe than we anticipated. New visa approvals for prospective students have slowed sharply and in some months declining as much as 80% versus the prior year. And in addition, the government has effectively closed the onshore transfer market by requiring international students already in Australia to obtain a new visa in order to change institutions. Given this environment, we have lowered our near-term growth expectations for the A and Z segment, which resulted in this quarter's $134 million non-cash impairment. Notwithstanding the headwinds on international enrollment, our domestic enrollment continues to fare well. Domestic new enrollment has grown every quarter this year, including 9% in each of the second and third quarters, and domestic students now represent close to 70% of New Enrollment in Australia. The quality of Torin's academic experience remains strong and has shown significant improvement over the past year. We were pleased to see Torin University's performance in the 2025 Quality Indicators for Learning and Teaching Student Experience Survey, the most comprehensive national survey of current higher education students in Australia. Torin's achieved widespread momentum across all undergraduate indicators, including a rise to sixth nationally for undergraduate teaching quality, up significantly from 19th the year before. At the postgraduate level, Torin continues to lead at the top tier of Australian higher education, ranking in the top four nationwide for both skills development and peer engagement, alongside a seventh place ranking in postgraduate teaching quality. This performance against national sector benchmarks reinforces Torin's value proposition and supports student retention and long-term brand equity in industry-aligned education. The quality of Torin's academic programs, combined with our own success in growing domestic enrollment, gives us confidence to increase our growth investments in Australia's domestic market in 2027. We are expanding our existing Adelaide campus and will launch several new health science programs and we also plan to open a new campus in Perth in late 2027. Western Australia is the fastest growing state in the country with population growth 50% higher than the national average. Greater Perth is projected to add more than a half a million residents over the next decade and its economy is concentrated in the sectors where our new programs are focused, namely healthcare, engineering, construction and defense. Perth will also position Torrens well for international recruitment from Asia when those constraints ease. Turning now to an update on our outlook versus our notional model. Given our current forecast for the balance of this year and the fact that the international enrollment environment in Australia deteriorated since the first half of the year, it appears unlikely our full year results will fall inside of our notional outlook. In terms of 2027, given that our forward revenue growth is mostly a product of current year enrollment, we think the most likely outcome for consolidated revenue next year is to be flat with this year. We expect the cost of the grossed investments that I have described this morning to be approximately $50 million in 2027. However, the productivity savings achieved this year will offset nearly half of that such that year-over-year increase in operating expenses will be limited to just 2%. Given that these incremental investments are targeted to support areas of proven strength at SEI, that is our two high-growth, high-margin platform businesses, our U.S. healthcare portfolio, and our domestic market growth in Australia, we have a high degree of confidence in their ability to return the company to its notional growth rates in 2028 and beyond. Regarding capital allocation, in addition to our regular quarterly dividend, we repurchased approximately 347,000 shares during the quarter for a total of $28.5 million. We ended the quarter with $139 million of cash and marketable securities and no debt. And finally, as always, I'd like to take this opportunity to thank all of my colleagues here at SCI for their ongoing commitment and support to our students and our corporate partners. and with that, Victor, we'd be happy to take questions.

Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.

Disclaimer

This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

-

-

Use this data in your own app

Pull this call's transcript, audio and slides with the Earnings call transcripts API.

See pricing

9,000+ companies · REST API

Investor presentation